Collaboration between industry and academia--prospects for male fertility control.
Drug development within the pharmaceutical industry is probably the field with the highest level of regulations. Due to the complexity of the different components of drug development and drug surveillance the need for a sophisticated organization and infrastructure is obvious. In addition, there is a necessity for sufficient resources and long-term commitment as well as logistic and long-term knowledge management. In order to secure high professional standards at all levels of this highly complex value creating chain, the number of cooperative arrangements in the pharmaceutical industry are increasing. The identification of new targets in the drug finding process calls in particular for outside partners. At the same time the preparedness of non-industrial researchers to cooperate with industry has also increased significantly. The area of fertility control, especially male fertility control, provides an excellent example for this kind of cooperation between industrial and non-industrial partners. Here a cooperative network is described which probably meets practically all relevant criteria for both the non-industrial but also the industrial partner. Some principles for the management of such a cooperative network are discussed. We believe that this kind of network can serve as a model for similar networks in other fields.
Stock
G
G
Schering AG, Berlin, Germany. guenter.stock@schering.de
Habenicht
U F
UF
D003272:Contraceptive Agents, Male; D003299:Cooperative Behavior; D004345:Drug Industry; D006801:Humans; D008297:Male; D017146:Models, Organizational; D016730:Program Development; D012106:Research
D003272:Contraceptive Agents, Male